exRNAdisease

Entry Detail

---



General Information

Database ID: exR0728817 RNA Name: hsa-miR-302c-3p RNA Type: miRNA Chromosome: chr4 Starnd: - Coordinate: Start Site(bp): 112648366 End Site(bp): 112648388 External Links: hsa-miR-302c-3p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE54010 Description: miRNA expression profiles in the 19 candidate urines (prostate cancer, CaP, patients and non-cancer subjects with benign prostatic hyperplasia, BPH) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Advanced Prostate Cancer Case Sample: Advanced Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 7 Number of Control: 5 Number of Samples: 12

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand MTMR12 chr5 32226994 32312987 - TXNIP chr1 145992435 145996579 - CLU chr8 27596917 27614700 - MBP chr18 76978827 77133683 - CCNB1 chr5 69167135 69178245 + SETD7 chr4 139495941 139606699 - NUP153 chr6 17615035 17706834 - SEC16A chr9 136440096 136483759 - SLAIN2 chr4 48341529 48426201 + ZSCAN26 chr6 28267010 28278224 + CUL1 chr7 148697914 148801110 + TRA2A chr7 23504780 23532041 - TEFM chr17 30897336 30906238 - CCNG2 chr4 77157207 77433388 + CDK6 chr7 92604921 92836594 - FYCO1 chr3 45917899 45995824 - PSMD5 chr9 120815496 120842951 - MTFR2 chr6 136231024 136250335 - VRK1 chr14 96797382 96931722 + UGP2 chr2 63840940 63891562 + KMT5B chr11 68154863 68213828 - SEMA3C chr7 80742538 80922359 - COX7C chr5 86617928 86620962 + SRRT chr7 100875103 100888664 + BCL7A chr12 122019422 122062044 + PDXK chr21 43719094 43762307 + MOB1A chr2 74152528 74178898 - MSTO1 chr1 155610188 155614971 + NPC2 chr14 74476192 74494177 - CAMK2N1 chr1 20482391 20486210 - miRNA targets: NA circRNA targets: circRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand hsa_circ_0000943 chr19 47421744 47440665 + lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC011503.2 chr19 23927788 23929287 + AC125257.1 chr17 41848518 41851447 - AL049840.4 chr14 103694516 103695050 - ARHGAP27P1-BPTFP1-KPNA2P3 chr17 64749663 64781707 - FGD5-AS1 chr3 14920347 14948424 - MIR17HG chr13 91347820 91354579 + NEAT1 chr11 65422774 65445540 + NORAD chr20 36045618 36051018 - SNHG16 chr17 76557764 76565348 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE54010 Sample Source: Urine Source Fraction: Urine Platform: GPL15159 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1183 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted using RecoverAllTM Total Nucleic Acid Isolation kit (Life Technologies, Carlsbad, CA). RNA library preparation protocol: 400 ng of total RNA was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling kit and hybridized to the array according to the manufacturer's protocol.

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA